EV/EBITDA
-1.02
-0.01-0.99%
6 min ago
Summary
- As of February 21, 2025, ABOS EV/EBITDA is -1.02, with a fall of -0.01 (-0.99%) during the most recent trading day.
- Over the past year, ABOS EV/EBITDA has increased by +2.14 (+67.72%).
- ABOS EV/EBITDA is now -343.48% below its all-time high of -0.23.
Performance
ABOS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ABOS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.0% | +0.4% | +0.4% |
| 1 m1 month | +17.7% | -18.3% | -17.5% |
| 3 m3 months | +40.7% | -41.0% | -39.6% |
| 6 m6 months | +55.1% | -40.4% | -51.4% |
| ytdytd | +18.4% | -18.8% | -17.9% |
| 1 y1 year | +67.7% | -51.5% | -59.9% |
| 5 y5 years | - | - | - |
ABOS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -7.4% | -1.30 | +21.5% | |
| 3 m | 3-month | -0.95 | -7.4% | -1.91 | +46.6% |
| 6 m | 6-month | -0.95 | -7.4% | -2.45 | +58.4% |
| 1 y | 1-year | -0.95 | -7.4% | -4.39 | +76.8% |
| 3 y | 3-year | -0.23 | -343.5% | -10.14 | +89.9% |
| 5 y | 5-year | -0.23 | -343.5% | -67.08 | +98.5% |
| alltime | all time | -0.23 | -343.5% | -67.08 | +98.5% |
Acumen Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.02(-18.4%) |
| 2024 | -1.25(-64.2%) |
| Date | Value |
|---|---|
| 2023 | -3.49(+71.9%) |
| 2022 | -2.03(-73.7%) |
| 2021 | -7.73 |
FAQ
- What is Acumen Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Acumen Pharmaceuticals?
- What is ABOS EV/EBITDA year-to-date change?
- What is Acumen Pharmaceuticals EV/EBITDA year-on-year change?
What is Acumen Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of ABOS is -1.02
What is the all time high EV/EBITDA for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high EV/EBITDA is -0.23
What is ABOS EV/EBITDA year-to-date change?
Acumen Pharmaceuticals EV/EBITDA has changed by +0.23 (+18.40%) since the beginning of the year
What is Acumen Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, ABOS EV/EBITDA has changed by +2.14 (+67.72%)